Rakuten Securities’s Vertex Pharmaceuticals VRTX Stock Holding History

Rakuten Securities's VRTX Position: Q2 2026 in Review

Rakuten Securities increased its Vertex Pharmaceuticals (VRTX) stake by 40% in Q2 2026, buying an estimated $3.54K and bringing the position to 28 shares worth $13.9K. The position accounts for ﹤0.01% of the portfolio, ranked #423.

Rakuten Securities first reported a position in VRTX in Q4 2023 and has held it in 11 quarters since. The position peaked at $173K in Q4 2023. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

• Rakuten Securities held 28 shares of Vertex Pharmaceuticals worth $13.9K as of Q2 2026.
• Rakuten Securities bought 8 Vertex Pharmaceuticals shares in Q2 2026, an estimated $3.54K.
• Vertex Pharmaceuticals made up ﹤0.01% of Rakuten Securities's portfolio in Q2 2026, its #423 holding.
• Rakuten Securities first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
• Rakuten Securities's Vertex Pharmaceuticals position peaked at $173K in Q4 2023.
• 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.